Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients.
Saved in:
| Title: | Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients. |
|---|---|
| Authors: | Goel S; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Frost E; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Tarquinio K; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Kamat P; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Fitch T; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Stenger E; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., Liu K; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Qayed M; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States., He Z; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Westbrook A; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Williams KM; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States., Schoettler ML; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Sep 03; Vol. 15, pp. 1642939. Date of Electronic Publication: 2025 Sep 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40969253 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Goel+S%22">Goel S</searchLink>; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Frost+E%22">Frost E</searchLink>; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Tarquinio+K%22">Tarquinio K</searchLink>; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Kamat+P%22">Kamat P</searchLink>; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Fitch+T%22">Fitch T</searchLink>; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Stenger+E%22">Stenger E</searchLink>; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Liu+K%22">Liu K</searchLink>; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Qayed+M%22">Qayed M</searchLink>; Department of Pediatrics, Division of Critical Care Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22He+Z%22">He Z</searchLink>; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Westbrook+A%22">Westbrook A</searchLink>; Department of Biostatistics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Williams+KM%22">Williams KM</searchLink>; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Schoettler+ML%22">Schoettler ML</searchLink>; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Sep 03; Vol. 15, pp. 1642939. <i>Date of Electronic Publication: </i>2025 Sep 03 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40969253 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1642939 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1642939 Titles: – TitleFull: Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Goel S – PersonEntity: Name: NameFull: Frost E – PersonEntity: Name: NameFull: Tarquinio K – PersonEntity: Name: NameFull: Kamat P – PersonEntity: Name: NameFull: Fitch T – PersonEntity: Name: NameFull: Stenger E – PersonEntity: Name: NameFull: Liu K – PersonEntity: Name: NameFull: Qayed M – PersonEntity: Name: NameFull: He Z – PersonEntity: Name: NameFull: Westbrook A – PersonEntity: Name: NameFull: Williams KM – PersonEntity: Name: NameFull: Schoettler ML IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 09 Text: 2025 Sep 03 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |